Overview of the pharmacogenomics of cigarette smoking
暂无分享,去创建一个
R. Tyndale | R F Tyndale | M K Ho | M. K. Ho | MK Ho | RF Tyndale
[1] M. Spitz,et al. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] R. Anney,et al. Association Between Dependent Smoking and a Polymorphism in the Tyrosine Hydroxylase Gene in a Prospective Population-Based Study of Adolescent Health , 2004, Behavior genetics.
[3] N E Morton,et al. The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit , 2000, Annals of human genetics.
[4] R. Wurtman,et al. Effects of systemic nicotine on serotonin release in rat brain , 1993, Brain Research.
[5] N. Martin,et al. Defining nicotine dependence for genetic research: evidence from Australian twins , 2004, Psychological Medicine.
[6] K. Hutchison,et al. The DRD4 VNTR polymorphism influences reactivity to smoking cues. , 2002, Journal of abnormal psychology.
[7] N. Hamajima,et al. Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[8] J. Changeux,et al. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors , 2003, The European journal of neuroscience.
[9] Aker,et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.
[10] Michael C Neale,et al. Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[11] C. Husten,et al. Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.
[12] R. Drucker-Colín,et al. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. , 1998, European journal of pharmacology.
[13] A. Elfarra,et al. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. , 1994, Archives of biochemistry and biophysics.
[14] D. Hamer,et al. Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[15] D. Carmelli,et al. Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences. , 1990, Journal of substance abuse.
[16] C. Lerman,et al. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms , 2004, The Pharmacogenomics Journal.
[17] T. Arinami,et al. Polymorphisms in genes involved in neurotransmission in relation to smoking. , 2000, European journal of pharmacology.
[18] T. Fukami,et al. CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS , 2005, Drug Metabolism and Disposition.
[19] Z. Ismail,et al. Nicotine and Endogenous Opioids: Toward Specific Pharmacotherapy , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[20] L. Garofano,et al. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[21] J. Mallet,et al. Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. , 2001, Human molecular genetics.
[22] D. Greenblatt,et al. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[23] D. Sarkar,et al. The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. , 1997, Life sciences.
[24] C. Lerman,et al. Interacting effects of genetic predisposition and depression on adolescent smoking progression. , 2004, The American journal of psychiatry.
[25] A. Ishizaka,et al. Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms , 2006, European Respiratory Journal.
[26] V. Höllt,et al. Pharmacogenetics of opioid receptors and addiction , 2006, Pharmacogenetics and genomics.
[27] D. Bertrand,et al. Nicotine addiction: the possible role of functional upregulation. , 2002, Trends in pharmacological sciences.
[28] C. Stockmeier,et al. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. , 1999, The Journal of pharmacology and experimental therapeutics.
[29] Clinton D Kilts,et al. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density , 2005, BMC Genetics.
[30] M. Stitzer,et al. Pharmacotherapy for Nicotine Dependence 1 , 2005, CA: a cancer journal for clinicians.
[31] C. Lerman,et al. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers , 2005, Molecular Psychiatry.
[32] Y. Funae,et al. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. , 1996, The Journal of pharmacology and experimental therapeutics.
[33] D. Lancet,et al. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes , 2006, Molecular Psychiatry.
[34] P. Shields,et al. Tryptophan hydroxylase gene variant and smoking behavior. , 2001, American journal of medical genetics.
[35] A. Korten,et al. Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. , 2000, American journal of medical genetics.
[36] L. Almasy,et al. Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q , 1999, Genetic epidemiology.
[37] M. Nakajima,et al. TRANS-3′-HYDROXYCOTININE O- AND N-GLUCURONIDATIONS IN HUMAN LIVER MICROSOMES , 2005, Drug Metabolism and Disposition.
[38] K. Matsuo,et al. Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study. , 2002, Journal of epidemiology.
[39] M C Neale,et al. A population-based twin study in women of smoking initiation and nicotine dependence , 1999, Psychological Medicine.
[40] Y. Funae,et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[41] M. Neale,et al. Genome-wide Linkage Scan to Identify Loci for Age at First Cigarette in Dutch Sibling Pairs , 2006, Behavior genetics.
[42] Ming D. Li,et al. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. , 2003, Addiction.
[43] E. Bowman,et al. EVIDENCE SUGGESTING THE ROLE OF SPECIFIC GENETIC FACTORS IN CIGARETTE SMOKING , 1998 .
[44] P. Whiting,et al. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. , 1994, Molecular pharmacology.
[45] N. Martin,et al. Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data. , 2002, Twin research : the official journal of the International Society for Twin Studies.
[46] N. Martin,et al. Genetic contribution to risk of smoking initiation: comparisons across birth cohorts and across cultures. , 1993, Journal of substance abuse.
[47] L. Epstein,et al. Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results , 2005, Cancer Epidemiology Biomarkers & Prevention.
[48] K. Kiyotani,et al. Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. , 2005, Biochemical and biophysical research communications.
[49] K. Matsuo,et al. Association of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults , 2003, Journal of epidemiology.
[50] D Hoffmann,et al. The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.
[51] M. Munafo,et al. Pharmacogenetics and nicotine addiction treatment. , 2005, Pharmacogenomics.
[52] Ming D. Li,et al. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. , 2005, Human molecular genetics.
[53] E. Lander,et al. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.
[54] M. Munafo,et al. Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.
[55] D. Grandy,et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.
[56] L. Kozlowski,et al. Influence of Smoking Fewer Cigarettes on Exposure to Tar, Nicotine, and Carbon Monoxide , 1987 .
[57] D. Comings,et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors , 1997, Molecular Psychiatry.
[58] R. Tyndale,et al. Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.
[59] M. Tsuang,et al. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[60] Ming D. Li. The genetics of nicotine dependence , 2006, Current psychiatry reports.
[61] P. Sullivan,et al. Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study , 1999, Molecular Psychiatry.
[62] C. Ehlers,et al. Genomic screen for loci associated with tobacco usage in Mission Indians , 2006, BMC Medical Genetics.
[63] R. Tyndale,et al. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[64] B R Flay,et al. Stages in the development of adolescent smoking. , 2000, Drug and alcohol dependence.
[65] R. Tyndale,et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers , 2004, Tobacco Control.
[66] R. Tyndale,et al. Nicotine metabolism defect reduces smoking , 1998, Nature.
[67] A. Yoshino,et al. Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. , 2004, Alcoholism, clinical and experimental research.
[68] T. Clark,et al. Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study. , 2002, Pharmacogenetics.
[69] R. Foxx,et al. Nicotine's role in smoking: an analysis of nicotine regulation. , 1983, Psychological bulletin.
[70] P. Sullivan,et al. A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence , 2004, Psychological Medicine.
[71] H. Checkoway,et al. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men , 2005, Neuroscience Letters.
[72] Jun Yokota,et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[73] N. Martin,et al. The Genetics of Smoking Persistence in Men and Women: A Multicultural Study , 1999, Behavior genetics.
[74] M. Spitz,et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.
[75] H. Edenberg,et al. The contribution of genetics to addiction therapy approaches. , 2005, Pharmacology & therapeutics.
[76] L. Epstein,et al. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[77] R. Tyndale,et al. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[78] K. Bucholz,et al. Common genetic vulnerability for nicotine and alcohol dependence in men. , 1999, Archives of general psychiatry.
[79] R. Tyndale,et al. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. , 1997, The Journal of pharmacology and experimental therapeutics.
[80] L. Kozlowski,et al. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[81] G. Willemsen,et al. Linkage analysis of smoking initiation and quantity in Dutch sibling pairs , 2004, The Pharmacogenomics Journal.
[82] Mariza de Andrade,et al. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[83] J. Feighner,et al. Bupropion: a review of its mechanism of antidepressant activity. , 1995, The Journal of clinical psychiatry.
[84] L. Cardon,et al. The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. , 1996, Journal of substance abuse.
[85] Gonneke Willemsen,et al. Heritability of Smoking Initiation and Nicotine Dependence , 2005, Behavior genetics.
[86] K. Kellar,et al. Differential Regulation of Neuronal Nicotinic Receptor Binding Sites Following Chronic Nicotine Administration , 1997, Journal of neurochemistry.
[87] Hongyu Zhao,et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus , 1998, Human Genetics.
[88] G. Koob,et al. Dramatic decreases in brain reward function during nicotine withdrawal , 1998, Nature.
[89] J. Marx. Drug development. Drugs inspired by a drug. , 2006, Science.
[90] R. Perera,et al. Nicotine replacement therapy for smoking cessation. , 2012, The Cochrane database of systematic reviews.
[91] Ming D. Li,et al. Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. , 2005, American journal of human genetics.
[92] M. Neville,et al. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.
[93] M. Lynskey,et al. The genetics of tobacco use: methods, findings and policy implications , 2002, Tobacco control.
[94] J. Kaprio,et al. Genetic Architecture of Smoking Behavior: A Study of Finnish Adult Twins , 2006, Twin Research and Human Genetics.
[95] C. Lerman,et al. An association of CYP2A6 genotype and smoking topography. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[96] David Goldman,et al. COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms. , 2005, Journal of studies on alcohol. Supplement.
[97] S. Rogers,et al. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. , 1992, Molecular pharmacology.
[98] Tianhua Niu,et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. , 2004, American journal of human genetics.
[99] Gail P Jarvik,et al. Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study , 2003, BMC Genetics.
[100] Martin H. Schmidt,et al. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking? , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[101] A. Lajtha,et al. The Effects of Cholinergic and Dopaminergic Antagonists on Nicotine-Induced Cerebral Neurotransmitter Changes , 2005, Neurochemical Research.
[102] M. Loriot,et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. , 2001, Pharmacogenetics.
[103] D. Murphy,et al. A genetic association for cigarette smoking behavior. , 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[104] S. David,et al. Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels". , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[105] A. Houdi,et al. Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brain , 1990, Neuroscience Letters.
[106] J. Changeux,et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.
[107] D. Comings,et al. ORIGINAL RESEARCH ARTICLE Studies of the potential role of the dopamine D 1 receptor gene in addictive behaviors , 1997 .
[108] A. Kastin,et al. A potent and selective endogenous agonist for the mu-opiate receptor. , 1997, Nature.
[109] M. Krebs,et al. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population , 2006, The Pharmacogenomics Journal.
[110] R P Mattick,et al. Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. , 2010, Australian journal of public health.
[111] V. Hesselbrock,et al. Results of a genomewide linkage scan: Support for chromosomes 9 and 11 loci increasing risk for cigarette smoking , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[112] G. Swan,et al. Non-replication of genetic association studies: is DAT all, folks? , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[113] P. Sullivan,et al. Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. , 2000, American journal of medical genetics.
[114] P. Männistö,et al. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.
[115] C. Lerman,et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation , 2006, Clinical pharmacology and therapeutics.
[116] T. Niu,et al. Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence , 2004, Journal of Human Genetics.
[117] M. Munafo,et al. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial , 2004, BMJ : British Medical Journal.
[118] R. Lukas,et al. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. , 1999, The Journal of pharmacology and experimental therapeutics.
[119] Eric L. Barker,et al. Serotonin transporters: Implications for antidepressant drug development , 2005, The AAPS Journal.
[120] C. Jepson,et al. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy , 2006, Molecular Psychiatry.
[121] G. Coetzee,et al. Genetic variation of CYP2A6, smoking, and risk of cancer , 1999, The Lancet.
[122] A. Goldstein,et al. A genome‐wide search for loci contributing to smoking and alcoholism , 1999, Genetic epidemiology.
[123] Ming D. Li,et al. Significant association of BDNF haplotypes in European‐American male smokers but not in European‐American female or African‐American smokers , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[124] D. Comings,et al. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. , 1996, Pharmacogenetics.
[125] J O Rinne,et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.
[126] X Li,et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.
[127] Vincenzo De Luca,et al. Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients , 2004, Neuropsychopharmacology.
[128] B. Greenberg,et al. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior , 2000, Molecular Psychiatry.
[129] K. Franklin,et al. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine , 2005, Psychopharmacology.
[130] C. McLoughlin. Nicotine replacement. , 2005, Professional nurse.
[131] S. David,et al. No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. , 2002, Pharmacogenetics.
[132] Ming D. Li,et al. Significant Association of Catechol-O-Methyltransferase (COMT) Haplotypes with Nicotine Dependence in Male and Female Smokers of Two Ethnic Populations , 2006, Neuropsychopharmacology.
[133] R. Walton,et al. The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population , 2004, Addiction biology.
[134] K. Kendler,et al. Tobacco consumption in Swedish twins reared apart and reared together. , 2000, Archives of general psychiatry.
[135] R Freedman,et al. Schizophrenia, sensory gating, and nicotinic receptors. , 1998, Schizophrenia bulletin.
[136] P Riederer,et al. Allelic Variation of Human Serotonin Transporter Gene Expression , 1996, Journal of neurochemistry.
[137] Ming D. Li,et al. A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population , 2003, BMC Genetics.
[138] D. Grandy,et al. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. , 1991, Genomics.
[139] Scott F. Saccone,et al. Genetic analysis of maximum cigarette-use phenotypes , 2003, BMC Genetics.
[140] R. Makuch,et al. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. , 2006, Archives of internal medicine.
[141] R. Tyndale,et al. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. , 2000, Molecular pharmacology.
[142] C. Husten,et al. Cigarette Smoking Among Adults, United States , 2006 .
[143] Yonghua Hu,et al. Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males. , 2006, The international journal of neuropsychopharmacology.
[144] R. Ebstein,et al. Association of the serotonin transporter gene with smoking behavior. , 2005, The American journal of psychiatry.
[145] R. J. Mitchell,et al. Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations. , 2000, Human biology.
[146] Veena Kumari,et al. Nicotine use in schizophrenia: The self medication hypotheses , 2005, Neuroscience & Biobehavioral Reviews.
[147] D. Hamer,et al. Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2). , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[148] P. Courtet,et al. Suicidal behavior: Relationship between phenotype and serotonergic genotype , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.
[149] P. Robledo,et al. Nicotine-Induced Antinociception, Rewarding Effects, and Physical Dependence Are Decreased in Mice Lacking the Preproenkephalin Gene , 2005, The Journal of Neuroscience.
[150] E. Bowman,et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[151] L. Kozlowski,et al. DAT's not all, but it may be more than we realize. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[152] U. Spampinato,et al. 5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum , 2002, Neuropsychopharmacology.
[153] D. Mant,et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. , 2000, Pharmacogenetics.
[154] Philip Asherson,et al. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1) , 2005, BMC Genetics.
[155] D. Blakely,et al. Population genetic study of the human dopamine transporter gene (DAT1) , 1995, Genetic epidemiology.
[156] S. David,et al. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[157] J. Jefferson,et al. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. , 2005, Clinical therapeutics.
[158] N. Benowitz. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. , 1988, The New England journal of medicine.
[159] I. Ulmanen,et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.
[160] N. Benowitz,et al. Nicotine renal excretion rate influences nicotine intake during cigarette smoking. , 1985, The Journal of pharmacology and experimental therapeutics.
[161] Hiroshi Yamamoto,et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans , 2001, Clinical pharmacology and therapeutics.
[162] T. George,et al. Co-morbidity of smoking in patients with psychiatric and substance use disorders. , 2005, The American journal on addictions.
[163] N. Benowitz,et al. Metabolism of nicotine to cotinine studied by a dual stable isotope method , 1994, Clinical pharmacology and therapeutics.
[164] T. Arinami,et al. Association between serotonin transporter gene polymorphism and smoking among Japanese males. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[165] N. Martin,et al. A Possible Smoking Susceptibility Locus on Chromosome 11p12: Evidence from Sex-limitation Linkage Analyses in a Sample of Australian Twin Families , 2006, Behavior genetics.
[166] B. Cravatt,et al. A missense mutation in human fatty acid amide hydrolase associated with problem drug use , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[167] W. Tan,et al. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population , 2001, International journal of cancer.
[168] Darrell R. Schroeder,et al. A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .
[169] C. Morris,et al. Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. , 1998, Pharmacogenetics.
[170] T. Arinami,et al. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.
[171] K. Matsuo,et al. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. , 2003, Pharmacogenetics.
[172] Anna M. Lee,et al. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment , 2006, Journal of psychopharmacology.
[173] B. Carter,et al. A meta-analytic review of the CYP2A6 genotype and smoking behavior. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[174] D. Balfour. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[175] J. Changeux,et al. Genetic dissociation of two behaviors associated with nicotine addiction: Beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome , 2006, Psychopharmacology.
[176] S. S. St. Jeor,et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? , 1994, Medical hypotheses.
[177] R. Tyndale,et al. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking , 2000, Clinical pharmacology and therapeutics.
[178] R. Tyndale,et al. Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.
[179] J. Blendy,et al. μ-Opioid Receptor and CREB Activation Are Required for Nicotine Reward , 2005, Neuron.
[180] C. Lerman,et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial , 2004, The Pharmacogenomics Journal.
[181] D. Cook,et al. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents , 2005, Pharmacogenetics and genomics.
[182] R. Tyndale,et al. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. , 2004, Pharmacogenetics.
[183] P. Shields,et al. Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking. , 1997, Pharmacogenetics.
[184] W. Geldenhuys,et al. Brain Uptake Kinetics of Nicotine and Cotinine after Chronic Nicotine Exposure , 2005, Journal of Pharmacology and Experimental Therapeutics.
[185] P. Sokoloff,et al. Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects , 2005, Neuropsychopharmacology.
[186] J. Yokota,et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. , 2004, Carcinogenesis.
[187] M. Tsuang,et al. Genetic and environmental contributions to smoking. , 1997, Addiction.
[188] P. Sullivan,et al. The genetic epidemiology of smoking. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[189] W. März,et al. The serotonin transporter gene polymorphism is not associated with smoking behavior , 2006, The Pharmacogenomics Journal.
[190] P. Shields,et al. The role of the serotonin transporter gene in cigarette smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[191] N. Benowitz,et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity , 2004, Clinical pharmacology and therapeutics.
[192] S. Wonnacott,et al. Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.
[193] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[194] G. Swan,et al. Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR , 2005, The Pharmacogenomics Journal.
[195] K. Iwahashi,et al. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population. , 2001, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.
[196] B. Cravatt,et al. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. , 2004, Human molecular genetics.
[197] L. Epstein,et al. Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.
[198] J. Marx. Drugs Inspired by a Drug , 2006, Science.
[199] J. Zhang,et al. Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area , 2000, Psychopharmacology.
[200] P. Sullivan,et al. An association study of DRD5 with smoking initiation and progression to nicotine dependence. , 2001, American journal of medical genetics.
[201] D. Hamer,et al. A functional polymorphism in the monoamine oxidase A gene promoter , 1998, Human Genetics.
[202] P. Sullivan,et al. Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. , 2001, American journal of medical genetics.
[203] M. Munafo,et al. The genetic basis for smoking behavior: a systematic review and meta-analysis. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[204] L. Bierut,et al. Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. , 2000, American journal of medical genetics.
[205] G. Saucier,et al. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence , 1999, Molecular Psychiatry.
[206] M. Reuter,et al. Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[207] A. C. Collins,et al. Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization , 2004, Science.
[208] L. Cardon,et al. Heavy consumption of cigarettes, alcohol and coffee in male twins. , 1997, Journal of studies on alcohol.
[209] M. Nakajima,et al. Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. , 2005, Drug metabolism and pharmacokinetics.
[210] M. Damaj,et al. Bupropion is a nicotinic antagonist. , 2000, The Journal of pharmacology and experimental therapeutics.
[211] Caryn Lerman,et al. Genetics and Drug Use as a Complex Phenotype , 2004, Substance use & misuse.
[212] E K Perry,et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. , 1997, Pharmacogenetics.
[213] L. Bierut,et al. A genomic scan for habitual smoking in families of alcoholics: Common and specific genetic factors in substance dependence , 2004, American journal of medical genetics. Part A.
[214] M. Farré,et al. Drug addiction. , 2003, The New England journal of medicine.
[215] Kiyoshi Inoue,et al. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes , 1999, Archives of Toxicology.
[216] G. Uhl,et al. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. , 1992, Brain research. Molecular brain research.
[217] E P Noble,et al. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.
[218] W. Corrigall,et al. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area , 1994, Brain Research.
[219] T Yamamoto,et al. Nicotine metabolism and CYP2A6 allele frequencies in Koreans. , 2001, Pharmacogenetics.
[220] M. Neale,et al. The Genetics of Smoking Initiation and Quantity Smoked in Dutch Adolescent and Young Adult Twins , 1999, Behavior genetics.
[221] Hiroshi Yamamoto,et al. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans , 2000, Clinical pharmacology and therapeutics.
[222] Ming T. Tsuang,et al. A Novel Permutation Testing Method Implicates Sixteen Nicotinic Acetylcholine Receptor Genes as Risk Factors for Smoking in Schizophrenia Families , 2004, Human Heredity.
[223] R. Walton,et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. , 2004, Pharmacogenetics.
[224] M. Krebs,et al. Genetic vulnerability to drug abuse , 2000, European Psychiatry.
[225] L. Epstein,et al. Pharmacogenetic investigation of smoking cessation treatment. , 2002, Pharmacogenetics.
[226] N. Martin,et al. Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. , 1993, Addictive behaviors.
[227] Makiko Maeda,et al. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation , 2006, The Pharmacogenomics Journal.
[228] D. Mash,et al. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain , 2003, Neuropharmacology.
[229] U. Hofmann,et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. , 2001, Pharmacogenetics.
[230] R. Anney,et al. Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism. , 2004, Pharmacogenetics.
[231] R Pickens,et al. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. , 1992, Archives of general psychiatry.
[232] T. Rebbeck,et al. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women , 2005, Pharmacogenetics and genomics.
[233] K. Hashimoto,et al. Association study between brain‐derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[234] C. O'brien. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. , 2005, The American journal of psychiatry.
[235] H. Feiler,et al. A genome‐wide screen for nicotine dependence susceptibility loci , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.